Samik Basu

Company: Cabaletta Bio

Job title: Chief Scientific Officer

Seminars:

Panel Discussion: Exploring the Opportunities for Cell Therapies to Treat Indications Beyond Oncology 12:30 pm

• Do cell therapies have the potential to treat non-oncology indications? I.e. autoimmune disorders, infections, fibrosis and more • What are the main scientific challenges that lie ahead? • How do we navigate the regulatory landscape?Read more

day: Day 2 - Track B - Morning

Precision Medicine for Autoimmunity: Mechanism of Action for CAAR-T Cell Therapy & Applications to B Cell-Mediated Autoimmune Disease 11:00 am

• Reviewing mechanism of action for the CAAR-T platform that is designed to recognise and eliminate only the B-cells that cause autoimmune disease in patients • Discussing emerging clinical and translational insights from DesCAARTes trial of DSG3-CAART • Sharing rationale for indication prioritisation along with pre-clinical development path for new product candidatesRead more

day: Day 2 - Track B - Morning